• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Coronary Vasospasm - Pipeline Review, Q1 2011 - Product Image

Coronary Vasospasm - Pipeline Review, Q1 2011

  • ID: 1524662
  • January 2011
  • 18 pages
  • Global Markets Direct

Coronary Vasospasm - Pipeline Review, Q1 2011

Summary

Global Markets Direct’s, 'Coronary Vasospasm - Pipeline Review, Q1 2011', provides an overview of the Coronary Vasospasm therapeutic pipeline. This report provides information on the therapeutic development for Coronary Vasospasm, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Coronary Vasospasm. 'Coronary Vasospasm - Pipeline Review, Q1 2011' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- A snapshot of the global therapeutic scenario for Coronary Vasospasm.
- A review of the Coronary Vasospasm products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development READ MORE >



List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Coronary Vasospasm Overview
Therapeutics Development
An Overview of Pipeline Products for Coronary Vasospasm
Coronary Vasospasm Therapeutics under Development by Companies
Coronary Vasospasm Therapeutics under Investigation by Universities/Institutes
Universities/Institutes Involved in Coronary Vasospasm Therapeutics Development
Coronary Vasospasm Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Late Stage Drug Profiles – Universities/Institutes
Sildenafil - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products Under Development for Coronary Vasospasm , 2011
Products under Development for Coronary Vasospasm – Comparative Analysis, 2011
Assessment by Monotherapy Products, 2011
Assessment by Stage and Route of Administration, 2011
Assessment by Molecule Type, 2011

List of Figures
Number of Products under Development for Coronary Vasospasm , 2011
Products under Development for Coronary Vasospasm – Comparative Analysis, 2011
Products under Development by Companies, 2011
Products under Investigation by Universities/Institutes, 2011
Assessment by Monotherapy Products, 2011
Assessment by Route of Administration, 2011
Assessment by Stage and Route of Administration, 2011
Assessment by Molecule Type, 2011
Assessment by Stage and Molecule Type, 2011

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos